Bagsværd, Denmark, 25 June 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), also referred to as the Safe Harbour rules. This programme is part of the overall share repurchase programme of up to DKK 14 billion to be executed during a 12-month period beginning 1 February 2018.
Under the programme initiated 4 May 2018, Novo Nordisk will repurchase B shares for an amount up to DKK 2.7 billion in the period from 7 May 2018 to 6 August 2018.
Further information
| Media: | ||
| Katrine Sperling | +45 4442 6718 | |
| Ken Inchausti (US) | +1 609 786 8316 | |
| Investors: | ||
| Peter Hugreffe Ankersen | +45 3075 9085 | |
| Anders Mikkelsen | +45 3079 4461 | |
| Christina Kjær | +45 3079 3009 |
Company Announcement No 52 / 2018
Attachment